Yousif Capital Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.85M Sell
75,700
-10,085
-12% -$845K 0.08% 241
2026
Q1
$6.87M Buy
85,785
+7,755
+10% +$639K 0.08% 231
2025
Q4
$6.51M Sell
78,030
-3,972
-5% -$326K 0.07% 253
2025
Q3
$6.38M Sell
82,002
-3,741
-4% -$292K 0.07% 260
2025
Q2
$6.71M Sell
85,743
-1,890
-2% -$141K 0.07% 252
2025
Q1
$6.35M Hold
87,633
0.07% 251
2024
Q4
$6.49M Sell
87,633
-6,314
-7% -$442K 0.07% 253
2024
Q3
$6.2M Buy
93,947
+546
+0.6% +$39.7K 0.07% 274
2024
Q2
$8.63M Sell
93,401
-1,595
-2% -$141K 0.1% 182
2024
Q1
$9.08M Sell
94,996
-1,855
-2% -$156K 0.1% 193
2023
Q4
$7.38M Sell
96,851
-1,834
-2% -$128K 0.09% 212
2023
Q3
$6.84M Sell
98,685
-1,584
-2% -$127K 0.09% 222
2023
Q2
$9.46M Buy
100,269
+733
+0.7% +$63.7K 0.12% 161
2023
Q1
$8.23M Sell
99,536
-2,034
-2% -$160K 0.11% 180
2022
Q4
$7.58M Buy
101,570
+6,910
+7% +$533K 0.1% 197
2022
Q3
$7.82M Sell
94,660
-953
-1% -$91.7K 0.11% 180
2022
Q2
$9.09M Sell
95,613
-1,555
-2% -$161K 0.12% 162
2022
Q1
$11.4M Buy
97,168
+2,511
+3% +$282K 0.12% 143
2021
Q4
$12.3M Buy
+94,657
New +$11M 0.13% 141

Other funds holding EW

Yousif Capital Management's EW Position: Q2 2026 in Review

Yousif Capital Management reduced its Edwards Lifesciences (EW) stake by 12% in Q2 2026, selling an estimated $845K and leaving 75,700 shares worth $6.85M. The position accounts for 0.08% of the portfolio, ranked #241.

Yousif Capital Management first reported a position in EW in Q4 2021 and has held it in 19 quarters since. The position peaked at $12.3M in Q4 2021. 287 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Yousif Capital Management held 75,700 shares of Edwards Lifesciences worth $6.85M as of Q2 2026.
  • Yousif Capital Management sold 10,085 Edwards Lifesciences shares in Q2 2026, an estimated $845K.
  • Edwards Lifesciences made up 0.08% of Yousif Capital Management's portfolio in Q2 2026, its #241 holding.
  • Yousif Capital Management first reported a position in Edwards Lifesciences in Q4 2021 and has held it in 19 quarters since.
  • Yousif Capital Management's Edwards Lifesciences position peaked at $12.3M in Q4 2021.
  • 287 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Yousif Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.